This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessCase Report
First Reported Case of Acute Kidney Injury Following Intraureteral Indocyanine Green Administration During Bilateral Endometrioma Excision
by
Anna Scholz
Anna Scholz 1,*,
Olga Redko
Olga Redko 2,
Michał Kostrzanowski
Michał Kostrzanowski 2
and
Filip Dąbrowski
Filip Dąbrowski 3
1
Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland
2
Department of Gynecology, Bielański Hospital, 01-809 Warsaw, Poland
3
Department of Gynecological Oncology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(24), 8758; https://doi.org/10.3390/jcm14248758 (registering DOI)
Submission received: 31 August 2025
/
Revised: 7 November 2025
/
Accepted: 8 November 2025
/
Published: 10 December 2025
Abstract
Indocyanine green (ICG) is widely used in minimally invasive surgery for real-time fluorescence imaging of vascular, biliary, and urological structures. Although its intravenous use has been extensively validated, data on intraureteral administration remain scarce, particularly regarding renal safety. We report the case of a 50-year-old woman undergoing laparoscopic bilateral endometrioma excision with intraureteral ICG instillation for ureteral visualisation. Despite an uneventful surgery, the patient developed anuria and acute kidney injury (AKI) within 24 h, requiring temporary hemodialysis. Imaging demonstrated bilateral renal dysfunction without evidence of ureteral transection. Renal function gradually improved with supportive care, and dialysis was discontinued. This is, to our knowledge, the first reported case of AKI following intraureteral ICG use. Potential mechanisms include dye-induced tubular toxicity, ischemic injury, and multifactorial perioperative stressors. Given the increasing adoption of near-infrared fluorescence in gynecologic and urologic surgery, our case highlights the urgent need for systematic studies on the renal safety of intraureteral ICG administration. Until further evidence emerges, surgeons should use the technique with caution, particularly in patients with preexisting risk factors for AKI.
Share and Cite
MDPI and ACS Style
Scholz, A.; Redko, O.; Kostrzanowski, M.; Dąbrowski, F.
First Reported Case of Acute Kidney Injury Following Intraureteral Indocyanine Green Administration During Bilateral Endometrioma Excision. J. Clin. Med. 2025, 14, 8758.
https://doi.org/10.3390/jcm14248758
AMA Style
Scholz A, Redko O, Kostrzanowski M, Dąbrowski F.
First Reported Case of Acute Kidney Injury Following Intraureteral Indocyanine Green Administration During Bilateral Endometrioma Excision. Journal of Clinical Medicine. 2025; 14(24):8758.
https://doi.org/10.3390/jcm14248758
Chicago/Turabian Style
Scholz, Anna, Olga Redko, Michał Kostrzanowski, and Filip Dąbrowski.
2025. "First Reported Case of Acute Kidney Injury Following Intraureteral Indocyanine Green Administration During Bilateral Endometrioma Excision" Journal of Clinical Medicine 14, no. 24: 8758.
https://doi.org/10.3390/jcm14248758
APA Style
Scholz, A., Redko, O., Kostrzanowski, M., & Dąbrowski, F.
(2025). First Reported Case of Acute Kidney Injury Following Intraureteral Indocyanine Green Administration During Bilateral Endometrioma Excision. Journal of Clinical Medicine, 14(24), 8758.
https://doi.org/10.3390/jcm14248758
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.